Mannatech to Officially Launch Mission 5 Million Movement in Branson, Mo.
Mannatech to Officially Launch Mission 5 Million Movement in Branson, Mo. Company Adopts Social Entrepreneurship to Help Fight Global Malnutrition Business Wire COPPELL, Texas -- August 29, 2013 Mannatech®, Incorporated (NASDAQ: MTEX) the pioneer of nutritional glycobiology and leading innovator of naturally-sourced supplements based on Real Food Technology^® solutions, is announcing the official launch of its Mission 5 Million^SM movement at the Branson2013 national conference this weekend in Branson, Missouri. The Mission 5 Million movement, or M5M^SM, represents the company’s commitment to linking five million consumers with five million children in need to help fight global malnutrition. According to the World Health Organization, approximately five million children are affected each year from issues related to undernourishment. Mission 5 Million marks a significant shift in Mannatech’s core business model, and its full commitment to social entrepreneurship specifically to help address the problem of undernourishment. Leveraging the same technology used in creating their premium supplements based on Real Food Technology solutions, Mannatech created PhytoBlend™ powder, a potent product specifically designed to bolster the nutritional value of the food provided to children by relief organizations worldwide. Every time a Mannatech product is purchased on automatic order, a donation is made to MannaRelief^†, a non-profit organization, who distributes PhytoBlend powder to orphanages and relief organizations all over the world. This simple approach allows anyone to help nourish the world by nourishing themselves with Mannatech products. In addition, Mannatech created the world’s first revenue-sharing rewards program for social entrepreneurship, allowing participants to earn income for championing the M5M movement by connecting consumers to Mannatech products. Combined with the company’s global infrastructure and patented product technologies, this revenue-sharing approach allows the company to actively incentivize those who champion the cause, aiming to shorten the timeline of reaching five million children in need. The Branson2013 event, themed “Hope for the Future,” will feature world-renowned and recently retired pediatric neurosurgeon, as well as humanitarian and best-selling author, Dr. Ben Carson. Other presentations focusing on different aspects of the Mission 5 Million movement will be shared throughout the weekend. In addition, the company will launch several new web-based tools and share some upcoming product announcements that will further ignite the M5M movement. “By combining the revolutionary technology that our products are based on with the passion and vision to make an impact in the fight against global malnutrition, we are marking the beginning of a new era of hope and health that’s going to change the world,” said Dr. Robert Sinnott, CEO and Chief Science Officer. “I’m simply proud to be a part of this company, and a part of this movement.” The event will be hosted by local Mannatech Independent Associates and attended by several corporate executives. The event will conclude with an official M5M flag-planting ceremony to symbolically launch the M5M era. To learn more about Mannatech and its Mission 5 Million movement, visit Mannatech.com. ^†MannaRelief is an independent, nonprofit organization. It is not owned or operated by Mannatech, Incorporated. About Mannatech Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of Social Entrepreneurship based on the foundation of promoting, aiding and optimizing nutrition where it is needed most around the world. Mannatech’s proprietary products are available through independent sales Associates around the globe including the United States, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan, Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech Republic, the Republic of Korea, Mexico, Namibia, Hong Kong and Ukraine. For more information, visit Mannatech.com. Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “believe,” “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain Associates and Members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release. Contact: Mannatech, Incorporated Brett Duncan, 972-471-7367 firstname.lastname@example.org